Canaglif 100 mg is a Product of the Generic Canagliflozin Hemihydrate

Canaglif 100 mg belongs to the generic category of Canagliflozin Hemihydrate. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Canaglif 100 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Canagliflozin Hemihydrate and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Canaglif 100 mg

Canaglif 100 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Canaglif 100 mg is provided below to help users gain a clear understanding of this medicine.

What Is Canaglif 100 mg Indications and Uses?

Canagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Pharmacology (Source, Chemical and Physical Composition) Of Canaglif 100 mg

Canagliflozin is an inhibitor of subtype-2 sodium-glucose co-transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter reduces the reabsorption of glucose from renal tubules, leading to more excretion of glucose in urine.

Dosage And Administration of Canaglif 100 mg

The recommended starting dose is 100 mg once daily, taken before the first meal of the day. Dose can be increased to 300 mg once daily who have CrCl>60 ml/min or who requires additional glycemic control. No dose adjustment is required for mild renal impairment. For moderate renal impairment (CrCl 45-60 ml/min) Canagliflozin 100 mg is recommended.

Drug Interactions of Canaglif 100 mg

UGT inducers (e.g. rifampin, phenytoin): Canagliflozin exposure is reduced. Consider increasing dose from 100 mg to 300 mg.Digoxin: Canagliflozin may slightly increase the concentration of digoxin in the body when both drugs are being taken.

Side Effects of Canaglif 100 mg

The most common adverse reactions of Canagliflozin are female genital mycotic infections, urinary tract infection and increased urination. Other side effects of Canagliflozin include low blood pressure, increases potassium blood levels (hyperkalemia), low blood glucose and increases Low-Density Lipoprotein (LDL-C).

Use During Pregnancy and Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. For nursing mother discontinue drug or nursing.

Precautions And Warnings for Canaglif 100 mg

Not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Therapeutic Class

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Storage Conditions of It

Keep in a dry place away from light and heat. Keep out of the reach of children.

Canaglif 100 mg is a Product of the Generic Canagliflozin Hemihydrate

Canaglif 100 mg

Square Pharmaceuticals PLC · Tablet

Canagliflozin Hemihydrate